Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987 - BellmuntJvon der Maase, H; Mead, GM (J Clin Oncol, 2012)
et al.